Trial Profile
Comparison of combination and monotherapy of rasagiline in Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2015
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 09 Nov 2015 New trial record